 | |  | |  | |  | |  | |  | |  |
CORPORATE FORMATION & VENTURE FINANCING
FDA Regulatory Strategy and Freedom-To-Operate ("FTO") Validation
To see presentations and articles on FDA Challenges in Corporate Formation &
Financing, click here ...
- ♦ Ensuring correct regulatory pathways
♦ Franchise protection (non-patent)
♦ Overcoming regulatory obstacles (e.g., Hatch-Waxman Exclusivity; generic
biologics)
♦ FDA regulatory process impact on FTO
- ♦ Assessing FDA-related strengths and weaknesses of targeted
companies/products
♦ Defending FDA status of targeted firm/product
♦ FDA compliance issues presented by target transactional parties
♦ FDA approval status assessments
- ♦ Product development and FDA-related milestones
♦ Indemnification – regulatory compliance
♦ Regulatory-related covenants, warranties & representations
To see presentations and articles on FDA Challenges in Corporate Formation &
Financing, click here ...
FDA Legal Services -- for the life of a Life Sciences company
 |
| |
 |
| |
 |
 |
| |
 |
| |
 |
| Product/Issue Specific FDA Legal Services |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| Ad Hoc FDA Legal Services |
Links to Our Other Services
| Life Cycle FDA Legal Services |
| ||||||||||||||||||||||||
|